Drug utilisation registry for Teflaro (ceftaroline fosamil)

Trial Profile

Drug utilisation registry for Teflaro (ceftaroline fosamil)

Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2017

At a glance

  • Drugs Ceftaroline fosamil (Primary)
  • Indications Bacteraemia; Community-acquired pneumonia; Methicillin-resistant Staphylococcus aureus infections; Nosocomial pneumonia; Osteomyelitis; Skin and soft tissue infections
  • Focus Therapeutic Use
  • Acronyms CAPTURE
  • Sponsors Cerexa; Forest Laboratories
  • Most Recent Events

    • 08 Oct 2017 Results (n=476) related to intensive care unit patients with pneumonia were presented at the IDWeek 2017
    • 08 Oct 2017 Results presented at the IDWeek 2017
    • 04 Oct 2017 According to an Allergan media release, data from the study will be presented At IDWeek 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top